| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |